Galera Therapeutics’ financing partners come from the top tier of biotech venture capital.

nea

  • Founded in 1977
  • Nearly $17 billion in committed capital invested across healthcare and technology sectors
  • Recent M&As include Hyperion Therapeutics, Omthera Pharmaceuticals

  • Over $750M under management
  • Invested in over 40 portfolio companies
  • Recent M&As include Alios BioPharma, Covagen, Heptares Therapeutics

  • Over $1.2B invested
  • 28 active portfolio companies
  • Recent M&As include Alios BioPharma, ProteinSimple, Santaris Pharma

  • A clinical-stage therapeutics focused investment firm
  • Approximately $2B under management
  • A committed team of MDs and PhDs that deploy human and financial capital to improve the lives of patients through science

  • Approximately $300M under management
  • Uses advanced analytics to inform investment decisions

  • Specializes in investments in groundbreaking biotechnology and materials-technology companies
  • Looks for companies with disruptive technology platforms with potential to become market leaders